<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37561027</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6613</ISSN><JournalIssue CitedMedium="Internet"><Volume>228</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>20</Day></PubDate></JournalIssue><Title>The Journal of infectious diseases</Title><ISOAbbreviation>J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>1662</StartPage><EndPage>1666</EndPage><MedlinePgn>1662-1666</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiad323</ELocationID><Abstract><AbstractText>We compared the serologic responses of 1 dose versus 2 doses of a variant vaccine (Moderna mRNA-1273 Beta/Omicron BA.1 bivalent vaccine) in adults. A 2-dose boosting regimen with a variant vaccine did not increase the magnitude or the durability of the serological responses compared to a single variant vaccine boost.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rouphael</LastName><ForeName>Nadine G</ForeName><Initials>NG</Initials><Identifier Source="ORCID">0000-0002-2512-7919</Identifier><AffiliationInfo><Affiliation>Hope Clinic, Emory University, Decatur, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Branche</LastName><ForeName>Angela R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Vaccine and Treatment Evaluation Unit, University of Rochester, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diemert</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0002-2789-0512</Identifier><AffiliationInfo><Affiliation>George Washington Vaccine Research Unit, George Washington University, Washington, District of Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falsey</LastName><ForeName>Ann R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Vaccine and Treatment Evaluation Unit, University of Rochester, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Losada</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hope Clinic, Emory University, Decatur, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baden</LastName><ForeName>Lindsey R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frey</LastName><ForeName>Sharon E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Center for Vaccine Development, Saint Louis University, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitaker</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Molecular Virology and Microbiology and Department of Medicine, Baylor College of Medicine, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Little</LastName><ForeName>Susan J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamidani</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6829-0700</Identifier><AffiliationInfo><Affiliation>Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Emory University, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walter</LastName><ForeName>Emmanuel B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novak</LastName><ForeName>Richard M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Project WISH, University of Illinois at Chicago, Chicago, Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rupp</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Lisa A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Washington Health Research Institute, Seattle, Washington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babu</LastName><ForeName>Tara M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kottkamp</LastName><ForeName>Angelica C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Vaccine and Treatment Evaluation Unit, Manhattan Research Clinic, New York University Grossman School of Medicine, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luetkemeyer</LastName><ForeName>Anne F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Immergluck</LastName><ForeName>Lilly C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Clinical Research Center, Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Presti</LastName><ForeName>Rachel M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Washington University School of Medicine, St Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xe4;cker</LastName><ForeName>Mart&#xed;n</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Vaccine and Treatment Evaluation Unit, Long Island Research Clinic, New York University Long Island School of Medicine, Mineola, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winokur</LastName><ForeName>Patricia L</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Iowa College of Medicine, Iowa City, Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahgoub</LastName><ForeName>Siham M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Howard University College of Medicine, Howard University Hospital, Washington, District of Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goepfert</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0001-8441-5737</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Alabama at Birmingham, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fusco</LastName><ForeName>Dahlene N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atmar</LastName><ForeName>Robert L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Molecular Virology and Microbiology and Department of Medicine, Baylor College of Medicine, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posavad</LastName><ForeName>Christine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Infectious Diseases Clinical Research Consortium (IDCRC) Laboratory Operations Unit, Fred Hutchinson Cancer Center, Seattle, Washington.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Netzl</LastName><ForeName>Antonia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Pathogen Evolution, Department of Zoology, University of Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Derek J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Centre for Pathogen Evolution, Department of Zoology, University of Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Telu</LastName><ForeName>Kalyani</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Emmes Company, LLC, Rockville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu</LastName><ForeName>Jinjian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Emmes Company, LLC, Rockville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McQuarrie</LastName><ForeName>Lisa J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>The Emmes Company, LLC, Rockville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makowski</LastName><ForeName>Mat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Emmes Company, LLC, Rockville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makhene</LastName><ForeName>Mamodikoe K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crandon</LastName><ForeName>Sonja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montefiori</LastName><ForeName>David C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Surgery, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Paul C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beigel</LastName><ForeName>John H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team
</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UM1 AI148450</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI069432</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N93021C00012</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI148685</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI165818</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>C0000008</GrantID><Acronym>CL</Acronym><Agency>CLC NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002378</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>HH</Acronym><Agency>HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI148575</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI148576</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Infect Dis</MedlineTA><NlmUniqueID>0413675</NlmUniqueID><ISSNLinking>0022-1899</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017778">Vaccines, Combined</NameOfSubstance></Chemical><Chemical><RegistryNumber>EPK39PL4R4</RegistryNumber><NameOfSubstance UI="D000090983">2019-nCoV Vaccine mRNA-1273</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2023 Jun 10:2023.06.06.23290973. doi: 10.1101/2023.06.06.23290973</RefSource><PMID Version="1">37333252</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017778" MajorTopicYN="N">Vaccines, Combined</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000090983" MajorTopicYN="Y">2019-nCoV Vaccine mRNA-1273</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002985" MajorTopicYN="N">Clinical Protocols</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword><Keyword MajorTopicYN="N">variant</Keyword></KeywordList><CoiStatement>Potential conflicts of interest. A. R. B. has received research support from NIH-NIAID, grants from Pfizer, Cyanvac, Moderna, Vaccine.co and Merck as well as consulting fees from Janssen and GSK. She serves as DSMB member for NIH, IDSA Public Health Committee. Honoraria as a speaker from Virology Education. L. R. B. has received grants from Wellcome Trust, Gates Foundation, NIH/Harvard Medical School through institution. Serves as member of DSMB for NIH and AMDAC for FDA. Dr Baden is involved in HIV and SARS-CoV-2 vaccine clinical trials conducted in collaboration with the NIH, HIV Vaccine Trials Network (HVTN), Covid Vaccine Prevention Network (CoVPN), International AIDS Vaccine Initiative (IAVI), Crucell/Janssen, Moderna, Military HIV Research Program (MHRP), the Gates Foundation, and Harvard Medical School. D. J. D. has received a contract from Leidos Biomedical/NIH research to conduct the clinical trial through institution. A. R. F. has received grants from Janssen, Pfizer, Merck, BioFire Diagnostics, Moderna, Vaccine company and CyanVac through institution. Consultant fees from Arrow Pharmaceutical, ADMA biologics, GSK, and honoraria as a speaker from Sanofi and GlaxoSmithKline. Serves as DSMB advisory boards for Novavax and received travel/meeting support from GlaxoSmithKline. S. E. F. has received funding from Leidos to Saint Louis University to conduct Protocol DMID 22-0004. Funding was also received to conduct the Moderna and Janssen trials phase 3 SARS-CoV-2 trials. Serves as DSMB for HVTN Safety Monitoring Board. D. N. F. has as a contract from CDC and is the site PI for DN Fusco study of COVID in Special Populations. D. N. F. served on an HBV Advisory board for Gilead related to hepatitis C &amp; B viruses and Axcella related to Long COVID. P. A. G. has received funding from NIH. PAG has a patent for COVID-19 monoclonal not developed clinically and received consulting fees from International AIDS Society as speaker. L. C. I. has received support from NIH, Moderna, Pfizer, and Sanofi. L. C. I. has also received grants from GSK, Merck, Sharpe &amp; Dohme Corp, CDC, Novavax, Pediatric Emergency Medicine Associates, and NIH/NLM/National Institute on Minority Health and Health Disparities as well as consulting fees from Moderna. L. C. I. has received honoraria as a speaker from American Academy of Pediatrics, Rockefeller University, Moderna, CDC and American Academy of Pediatrics- Georgia Chapter. L. C. I. Serves on Data Safety Monitoring for NIH-Phase 2 Vaccine Trial for Monkeypox, Moderna Scientific Advisory Board- North America, and CoVID-19 Task Force, Georgia. L. C. I. has a leadership role Break the Cycle of Health Disparities Inc, the Center for Spatial Analytics of the Georgia Institute of Technology, and the American Academy of Pediatrics (Executive Board for Section on Infectious Diseases). L. C. I. has received travel/meeting support from the American Academy of Pediatrics and Moderna. L. A. J. has received funding from NIH for support for this study, funding from Pfizer to support a clinical trial and contract funding for research support from the CDC and the NIH, all through institution. L. A. J. also reports unpaid participation on Data Safety Monitoring Boards for NIH funded clinical trials. S. K. has received research grants from NIH, Pfizer, U.S. Centers for Disease Control and Prevention, Meisa, Emergent BioSolutions. S. K. also received support from American Academy of Pediatrics as speaker. A. C. K. has received research support from COVID-19 Adaptive Variance Immunologic Landscape Trial # 28C15000NYUPG266894. S. J. L. has received NIH grants through institution. Consulting fees from Hookipa Pharma. A. F. L. has received grants from Merck, Gilead and, GSK through institution as well as consulting fees from Vir Biotechnology. A. F. L. has also received travel support from Merck to attend a required investigator meeting, testing kits and supplies to support research study from Hologic, Cepheid and medication donated by Mayne Pharma to support research study. M. M. has received funding from Emmes through NIH contract # HHSN272201500002C. L. J. M. has received funding from Emmes through NIH contract # HHSN272201500002C. D. C. M. has received funding from NIH/75N93019C00050-21A: CIVICS A- Option 21A-DMID Trials of COVID-19 Vaccines. J. M. has received funding from Division of Microbiology and Infectious Diseases, contract # 75N93021C00012. A. N. has received support from NIH-NIAID, CEIRR (Centers of Excellence for Influenza Research and Response) and Gates Cambridge Trust as well as grants from NIH-NIAID R01. R. M. N. has received grants from NIAID-DMID and travel/meeting support from Moderna. C. M. P. has received funding from NIAID UM1AI148684. R. M. P. has received funding from NIH DMID COVAIL as well as grants from Janssen, Moderna and NIH through institution. N. G. R. has received research grants from NIH, Pfizer, Merck, Sanofi, Quidel, Immorna, Vaccine Company and Lilly through her institution, consulting fees from Krog, honoraria as speaker for Virology education, and travel support from Sanofi and Moderna. N. G. R. serves as DSMB on safety committees for ICON, Micron and EMMES and is a member of the Moderna, Sanofi, Seqirus and Pfizer selected Advisory boards. Plays leadership advisory role for ARLG, TMRC, CDC-Pertussis challenge, Clinical Infectious Diseases. Equipment supports from Georgia Research Alliance. D. J. S. has received support from NIH-NIAID CEIRR, grants from NIH-NIAID R01, and travel support from NIH-NIAID CEIRR for NIH-related meetings. K. T. has received funding from Emmes through NIH contract # HHSN272201500002C. E. B. W. has received funding from Leidos Biomedical Research AGREEMENT NO. 22CTA-DM0009 as well as grants from Pfizer, Moderna, Sequiris, Clinetic, and Najit Technologies, with payments made to institution. E. B. W. has also received honoraria as a speaker from College of Diplomates of the American Board of Pediatric Dentistry, consulting fees from Iliad Biotechnologies, and travel/meeting support from the American Academy of Pediatrics. E. B. W. serves as member of Vaxcyte Scientific Advisory board. P. L. W. has received subcontract funding from NIH for this study as well as NIH grant funding and contract funding from Pfizer through University of Iowa. P. L. W. has also received consulting fees from Pfizer and serves on DSMB advisory board for Emmes Corporation, Blue Lake. M. B. has received research grants from Leidos Biomedical Research and Pfizer through institution. J. A. W. has received funding from NIH-DMID 75N91019D00024. R. L. A., T. M. B., S. M. M., M. K. M., J. H. B., S. C., C. L., P. C. R., R. R. authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Diemert</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malkin</LastName><ForeName>Elissa</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bethony</LastName><ForeName>Jeffrey M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Desrosiers</LastName><ForeName>Aimee</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Siegel</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Branche</LastName><ForeName>Angela R</ForeName><Initials>AR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Falsey</LastName><ForeName>Ann R</ForeName><Initials>AR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walsh</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kingsley</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peasley</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rouphael</LastName><ForeName>Nadine G</ForeName><Initials>NG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Losada</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graciaa</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Samaha</LastName><ForeName>Hady</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rebolledo</LastName><ForeName>Paulina A</ForeName><Initials>PA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wiley</LastName><ForeName>Zanthia</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baden</LastName><ForeName>Lindsey R</ForeName><Initials>LR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sherman</LastName><ForeName>Amy C</ForeName><Initials>AC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walsh</LastName><ForeName>Stephen R</ForeName><Initials>SR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tong</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rooks</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frey</LastName><ForeName>Sharon E</ForeName><Initials>SE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abate</LastName><ForeName>Getahun</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oikonomopoulou</LastName><ForeName>Zacharoula</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoft</LastName><ForeName>Daniel F</ForeName><Initials>DF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graham</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whitaker</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>El Sahly</LastName><ForeName>Hana M</ForeName><Initials>HM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Keitel</LastName><ForeName>Wendy A</ForeName><Initials>WA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Healy</LastName><ForeName>C Mary</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Atmar</LastName><ForeName>Robert L</ForeName><Initials>RL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Little</LastName><ForeName>Susan J</ForeName><Initials>SJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Thomas C S</ForeName><Initials>TCS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carter</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hendrickx</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anderson</LastName><ForeName>Evan J</ForeName><Initials>EJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rostad</LastName><ForeName>Christina A</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kamidani</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peters</LastName><ForeName>Etza</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walter</LastName><ForeName>Emmanuel B</ForeName><Initials>EB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moody</LastName><ForeName>M Anthony</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schmader</LastName><ForeName>Kenneth E</ForeName><Initials>KE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Novak</LastName><ForeName>Richard M</ForeName><Initials>RM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ladner</LastName><ForeName>Benjamin G</ForeName><Initials>BG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wendrow</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herrick</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rupp</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Porterfield</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jackson</LastName><ForeName>Lisa A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dunstan</LastName><ForeName>Maya</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lau</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carste</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Babu</LastName><ForeName>Tara M</ForeName><Initials>TM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wald</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krause</LastName><ForeName>Taylor</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hauge</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kottkamp</LastName><ForeName>Angelica C</ForeName><Initials>AC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mulligan</LastName><ForeName>Mark J</ForeName><Initials>MJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davis</LastName><ForeName>Tamia</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Engelson</LastName><ForeName>Celia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soma</LastName><ForeName>Vijaya</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luetkemeyer</LastName><ForeName>Anne F</ForeName><Initials>AF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Chloe</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lopez</LastName><ForeName>Azquena Munoz</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Immergluck</LastName><ForeName>Lilly C</ForeName><Initials>LC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Erica</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chan</LastName><ForeName>Austin</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Presti</LastName><ForeName>Rachel M</ForeName><Initials>RM</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Halloran</LastName><ForeName>Jane A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thompson</LastName><ForeName>Ryley M</ForeName><Initials>RM</Initials></Investigator><Investigator ValidYN="Y"><LastName>B&#xe4;cker</LastName><ForeName>Mart&#xed;n</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleming</LastName><ForeName>Andrew B</ForeName><Initials>AB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Joseph</LastName><ForeName>Sajumon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Winokur</LastName><ForeName>Patricia L</ForeName><Initials>PL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meier</LastName><ForeName>Jeffery</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stapleton</LastName><ForeName>Jack</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mahgoub</LastName><ForeName>Siham M</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maxwell</LastName><ForeName>Celia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shami</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goepfert</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fusco</LastName><ForeName>Dahlene N</ForeName><Initials>DN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drouin</LastName><ForeName>Arnaud C</ForeName><Initials>AC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Numbi</LastName><ForeName>Florice K</ForeName><Initials>FK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lyke</LastName><ForeName>Kirsten E</ForeName><Initials>KE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stephens</LastName><ForeName>David S</ForeName><Initials>DS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neuzil</LastName><ForeName>Kathleen M</ForeName><Initials>KM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farley</LastName><ForeName>Monica M</ForeName><Initials>MM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marrazzo</LastName><ForeName>Jeanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Young</LastName><ForeName>Sidnee Paschal</ForeName><Initials>SP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lennox</LastName><ForeName>Jeffery</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Atmar</LastName><ForeName>Robert L</ForeName><Initials>RL</Initials></Investigator><Investigator ValidYN="Y"><LastName>McNeil</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brown</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Posavad</LastName><ForeName>Christine M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meagher</LastName><ForeName>Megan A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>McElrath</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gale</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abebe</LastName><ForeName>Kuleni</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Makowski</LastName><ForeName>Mat</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hill</LastName><ForeName>Heather</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Albert</LastName><ForeName>Jim</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baughman</LastName><ForeName>Holly</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>McQuarrie</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Telu</LastName><ForeName>Kalyani</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mu</LastName><ForeName>Jinjian</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>McQuarrie</LastName><ForeName>Lisa J</ForeName><Initials>LJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lewis</LastName><ForeName>Teri C</ForeName><Initials>TC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giebeig</LastName><ForeName>Lisa A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Engel</LastName><ForeName>Theresa M</ForeName><Initials>TM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Griffith</LastName><ForeName>Caleb J</ForeName><Initials>CJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>McDonald</LastName><ForeName>Wendi L</ForeName><Initials>WL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burkey</LastName><ForeName>Alissa E</ForeName><Initials>AE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoopengardner</LastName><ForeName>Lisa B</ForeName><Initials>LB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Linton</LastName><ForeName>Jessica E</ForeName><Initials>JE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gettinger</LastName><ForeName>Nikki L</ForeName><Initials>NL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montefiori</LastName><ForeName>David C</ForeName><Initials>DC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eaton</LastName><ForeName>Amanda</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Derek J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Netzl</LastName><ForeName>Antonia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wilks</LastName><ForeName>Samuel H</ForeName><Initials>SH</Initials></Investigator><Investigator ValidYN="Y"><LastName>T&#xfc;reli</LastName><ForeName>Sina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Makhene</LastName><ForeName>Mamodikoe</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elsafy</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pikaart-Tautges</LastName><ForeName>Rhonda</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arega</LastName><ForeName>Janice</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoang</LastName><ForeName>Binh</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Curtin</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koo</LastName><ForeName>Hyung</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sindall</LastName><ForeName>Elisa</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crandon</LastName><ForeName>Sonja</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>DeGrace</LastName><ForeName>Marciela M</ForeName><Initials>MM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Post</LastName><ForeName>Diane J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nayak</LastName><ForeName>Seema U</ForeName><Initials>SU</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roberts</LastName><ForeName>Paul C</ForeName><Initials>PC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beigel</LastName><ForeName>John H</ForeName><Initials>JH</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>10</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>10</Day><Hour>10</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37561027</ArticleId><ArticleId IdType="pmc">PMC11032204</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiad323</ArticleId><ArticleId IdType="pii">7240453</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Branche &#xa0;AR, Rouphael &#xa0;NG, Diemert &#xa0;DJ, et al. &#xa0;SARS-CoV-2 Variant Vaccine Boosters Trial: preliminary analyses. medRxiv [Preprint]. Posted online 15 July 2022. doi:10.1101/2022.07.12.22277336</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.07.12.22277336</ArticleId></ArticleIdList></Reference><Reference><Citation>
US Food and Drug Administration . Coronavirus (COVID-19) update: FDA authorizes second booster dose of two COVID-19 vaccines for older and immunocompromised individuals. 2022. Available at: &#xa0;https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-second-booster-dose-two-covid-19-vaccines-older-and. Accessed 9 August 2023.</Citation></Reference><Reference><Citation>
US Food and Drug Administration . Updated COVID-19 vaccines for use in the United States beginning in fall 2023. 2023. Available at: https://www.fda.gov/vaccines-blood-biologics/updated-covid-19-vaccines-use-united-states-beginning-fall-2023. Accessed 21 July 2023.</Citation></Reference><Reference><Citation>Atmar &#xa0;RL, Lyke &#xa0;KE, Deming &#xa0;ME, et al. &#xa0;Homologous and heterologous COVID-19 booster vaccinations. N Engl J Med &#xa0;2022; 386:1046&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820244</ArticleId><ArticleId IdType="pubmed">35081293</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert &#xa0;PB, Montefiori &#xa0;DC, McDermott &#xa0;AB, et al. &#xa0;Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. Science &#xa0;2022; 375:43&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9017870</ArticleId><ArticleId IdType="pubmed">34812653</ArticleId></ArticleIdList></Reference><Reference><Citation>Link-Gelles &#xa0;R, Ciesla &#xa0;AA, Fleming-Dutra &#xa0;KE, et al. &#xa0;Effectiveness of bivalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection&#x2014;increasing community access to testing program, United States, September&#x2013;November 2022. MMWR Morb Mortal Wkly Rep &#xa0;2022; 71:1526&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9721148</ArticleId><ArticleId IdType="pubmed">36454688</ArticleId></ArticleIdList></Reference><Reference><Citation>Callaway &#xa0;E. The next generation of coronavirus vaccines: a graphical guide. Nature &#xa0;2023; 614:22&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">36726000</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>